This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Proximagen Limited. Active years: 2010.
Company Filing History:
Years Active: 2010
Title: Joanna Iczkiewicz: Innovator in Neurodegeneration Treatment
Joanna Iczkiewicz is a prominent inventor based in London, GB. She has made significant contributions to the field of neurodegeneration treatment through her innovative research and development.
Latest Patents
Joanna holds a patent for a treatment aimed at neurodegeneration. Her patent involves polypeptides that are N- and/or C-terminally truncated fragments of the human osteopontin (hOPN) sequence or species variant. These polypeptides minimally contain a 15 amino acid sequence corresponding to amino acids 138 to 152 of hOPN. The polynucleotides encoding these polypeptides are recognized for their potential utility in the treatment or prevention of neurodegeneration.
Career Highlights
Joanna has established herself as a key figure in her field, working at Proximagen Limited. Her work focuses on developing innovative solutions to combat neurodegenerative diseases, showcasing her dedication to advancing medical science.
Collaborations
Joanna collaborates with notable professionals in her field, including her coworker Peter Jenner. Their combined expertise contributes to the advancement of research and development in neurodegeneration treatment.
Conclusion
Joanna Iczkiewicz is a trailblazer in the field of neurodegeneration treatment, with her innovative patent and collaborative efforts paving the way for future advancements. Her work exemplifies the impact of dedicated inventors in the medical research landscape.